Reduction of Antitumour Mitosenes in Non-Aqueous and Aqueous Environment. An Electron Spin Resonance and Cyclic Voltammetry Study

References

• Hendriks H. R., Pizao P. E., Berger D. P., Kooistra K. L., Bibby M. C., Boven E., Dreef-van der Meulen H. C., Henrar R. E.C., Fiebig H. H., Double J. A., Hornstra H. W., Pinedo H. M., Workman P., Schwartsmann G. E09 - A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models. Eur. J. Cancer 1993; 29A: 897–906
   PubMed Web of Science ®Google Scholar
• Franck R. W., Tomasz M. The chemistry of mitomycins. The Chemistry of Antitumour Agents, E. V. Wilman. Blackie & Son Limited, Glasgow 1990; 379–394
   Google Scholar
• Tomasz M., Chowdary D., Lipman R., Shimotakahara S., Veiro D., Walker V., Verdine G. L. Reaction of DNA with chemically or enzymatically activated mitomycin C: Isolation and structure of the major covalent adduct. Proceedings of the National Academy of Sciences USA 1986; 83: 6702–6706
   PubMed Web of Science ®Google Scholar
• Tomasz M., Lipman R., McGuinness B. F., Nakanishi K. Isolation and characterization of a major adduct between mitomycin C and DNA. Journal of the American Chemical Society 1988; 110: 5892–5896
   Web of Science ®Google Scholar
• Tomasz M., Lipman R., Chowdary D., Pawlak J., Verdine G. L., Nakanishi K. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 1987; 235: 1204–1208
   PubMed Web of Science ®Google Scholar
• Kohn K. W. Biological aspects of DNA damage by crosslinking agents. Molecular Aspects of Anti-Cancer Drug Action, S. Neidle, M. J. Waring. Verlag Chemie, Weinheim 1983; 315–361
   Google Scholar
• Orlemans E. O.M., Verboom W., Scheltinga M. W., Reinhoudt D. N., Lelieveld P., Fiebig H. H., Winterhalter B. R., Double J. A., Bibby M. C. Synthesis, mechanism of action, and biological evaluation of mitosenes. Journal of Medicinal Chemistry 1989; 32: 1612–1620
   PubMed Web of Science ®Google Scholar
• Maliepaard M., de Mol N. J., Janssen L. H.M., van der Neut W., Verboom W., Reinhoudt D. N. Role of lipophilicity in the in vitro antitumour activity of a series of new mitosene compounds. Anti-Cancer Drug Design 1992; 7: 415–425
   PubMedGoogle Scholar
• Maliepaard M., de Mol N. J., Janssen L. H.M., Hoogvliet J. C., van der Neut W., Verboom W., Reinhoudt D. N. Reductive activation of potential antitumor mitosene compounds. Journal of Medicinal Chemistry 1993; 36: 2091–2097
   PubMed Web of Science ®Google Scholar
• Wardman P. Bioreductive activation of quinones - Redox properties and thiol reactivity. Free Radical Research Communications 1990; 8: 219–229
   PubMed Web of Science ®Google Scholar
• Andrews P. A., Pan S.-S., Bachur N. R. Electrochemical reductive activation of mitomycin C. Journal of the American Chemical Society 1986; 108: 4158–4166
   Web of Science ®Google Scholar
• Powis G. Metabolism and reaction of quinoid anticancer agents. Pharmacology and Therapeutics 1987; 35: 57–162
   PubMed Web of Science ®Google Scholar
• Kappus H. Overview of enzyme systems involved in bioreduction of drugs and in redox cycling. Biochemical Pharmacology 1986; 35: 1–6
   PubMed Web of Science ®Google Scholar
• Guengerich F. P., Martin M. V. Purification of cytochrome P-450, NADPH-cytochrome P-450 reductase and epoxide hydratase from a single preparation of rat liver microsomes. Archives of Biochemistry and Biophysics 1980; 205: 365–379
   PubMed Web of Science ®Google Scholar
• Bansal S. K., Love J. H., Gurtoo H. L. Resolution by high-pressure liquid chromatography and partial characterization of multiple forms of cytochrome P-450 from hepatic microsomes of phenobarbital-treated rats. European Journal of Biochemistry 1985; 146: 23–33
   PubMedGoogle Scholar
• Massey V., Hemmerich P. A photochemical procedure for reduction of oxidation-reduction proteins employing deazariboflavin as catalyst. Journal of Biological Chemistry 1977; 252: 5612–5614
   PubMed Web of Science ®Google Scholar
• Goeptar A. R., te Koppele J. M., van Maanen J. M.S., Zoetemelk C. E.M., Vermeulen N. P.E. One-electron reductive bioactivation of 2,3,5,6-tetramethyl-benzoquinone by cytochrome P450. Biochemical Pharmacology 1992; 43: 343–352
   PubMed Web of Science ®Google Scholar
• Goeptar A. R., te Koppele J. M., Lamme E. K., Piqué J. M., Vermeulen N. P.E. Cytochrome P450 2B7-mediated one-electron reduction of adriamycin: A study with rat liver microsomes and purified enzymes. Molecular Pharmacology 1993; 44: 1267–1277
   PubMed Web of Science ®Google Scholar
• Vromans R. M., van de Straat R., Groeneveld M., Vermeulen N. P.E. One-electron reduction of mitomycin C by rat liver: Role of cytochrome P-450 and NADPH-cytochrome P-450 reductase. Xenobiotica 1990; 20: 967–978
   PubMed Web of Science ®Google Scholar
• Nagata C., Matsuyama A. On the mechanism of action of the carcinostatic antibiotic mitomycin C. Progress in antibiotics and anticancer chemotherapy. Proceedings of the 6th International Congress on Chemotherapy, Tokyo, Volume II. 1970; 423–427
   Google Scholar
• Kalyanaraman B., Peret-Reyes E., Mason R. P. Spin trapping and direct electron spin resonance investigations of the redox metabolism of quinone anticancer drugs. Biochimica Biophysica Acta 1980; 630: 119–130
   PubMed Web of Science ®Google Scholar
• Wardman P. Reduction potentials of one-electron couples involving free radicals in aqueous solution. Journal of Physical and Chemical Reference Data 1989; 18: 1637–1755
   Web of Science ®Google Scholar
• Janssen L. H.M., van Til A. L., van Duijneveldt F. B. Reductive activation and radical formation in a series of substituted benzoquinones. Thermodynamic and quantum chemical studies. Bioelectrochemistry and Bioenergetics 1992; 27: 161–178
   Web of Science ®Google Scholar
• Cresteil T., Jaiswal A. K. High levels of expression of the NAD(P)H-quinone oxido-reductase (NQO1) gene in tumor cells compared to normal cells of the same origin. Biochemical Pharmacology 1991; 42: 1021–1027
   PubMed Web of Science ®Google Scholar